Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Methadone, a full mu-opioid agonist, is the recommended treatment for opioid dependence during pregnancy. However, prenatal exposure to methadone is associated with a neonatal abstinence syndrome (NAS) characterized by central nervous system hyperirritability and autonomic nervous system dysfunction, which often requires medication and extended hospitalization. Buprenorphine, a partial mu-opioid agonist, is an alternative treatment for opioid dependence but has not been extensively studied in pregnancy. METHODS: We conducted a double-blind, double-dummy, flexible-dosing, randomized, controlled study in which buprenorphine and methadone were compared for use in the comprehensive care of 175 pregnant women with opioid dependency at eight international sites. Primary outcomes were the number of neonates requiring treatment for NAS, the peak NAS score, the total amount of morphine needed to treat NAS, the length of the hospital stay for neonates, and neonatal head circumference. RESULTS: Treatment was discontinued by 16 of the 89 women in the methadone group (18%) and 28 of the 86 women in the buprenorphine group (33%). A comparison of the 131 neonates whose mothers were followed to the end of pregnancy according to treatment group (with 58 exposed to buprenorphine and 73 exposed to methadone) showed that the former group required significantly less morphine (mean dose, 1.1 mg vs. 10.4 mg; P<0.0091), had a significantly shorter hospital stay (10.0 days vs. 17.5 days, P<0.0091), and had a significantly shorter duration of treatment for the neonatal abstinence syndrome (4.1 days vs. 9.9 days, P<0.003125) (P values calculated in accordance with prespecified thresholds for significance). There were no significant differences between groups in other primary or secondary outcomes or in the rates of maternal or neonatal adverse events. CONCLUSIONS: These results are consistent with the use of buprenorphine as an acceptable treatment for opioid dependence in pregnant women. (Funded by the National Institute on Drug Abuse; ClinicalTrials.gov number, NCT00271219.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the length, but not intensity, of neonatal abstinence syndrome and the neonates’ need for morphine relief was lower in women taking buprenorphine compared to methadone”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [134]
The cited source says what the claim attributes to it.
In the citing paper
“there was lower retention in the buprenorphine treated group.”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782 · cited 3×
“Eye, ear, nose, or throat problems 12 (14) 15 (17) 1 (1) 1 (2)”
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub3 · Cited by 501
A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence
Ling, W. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050035005 · Cited by 366 · cited 4×
“Obstetrical problems 29 (33) 23 (27) 3 (4) 4 (7)”
InfluentialBuprenorphine suppresses heroin use by heroin addicts
Mello, N. K., & Mendelson, J. H. (1980) · Science · doi:10.1126/science.7352279 · Cited by 298
Jones, H. E., Johnson, R. E., Jasinski, D. R., O’Grady, K. E., Chisholm, C. A., Choo, R. E., Crocetti, M., Dudas, R., Harrow, C., Huestis, M. A., et al. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.11.013 · Cited by 295
Self-citationOPIOID DEPENDENCE DURING PREGNANCY
Kaltenbach, K., Berghella, V., & Finnegan, L. (1998) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70362-4 · Cited by 287
Self-citation
Research works printed but not linked: 4
- 10.1111/j.1360-0443.1997.tb02877.x · doi:10.1111/j.1360-0443.1997.tb02877.x · Paper page
- Mattick RP, 2009, Cochrane Database Syst Rev, 3, CD002209
- Finnegan LP, Kaltenbach K. Neonatal abstinence syndrome. In Hoekelman RA, Friedman SB, Nelson NM, et al., eds. Primary pediatric care. 2nd ed. St. Louis: Mosby, 1992:1367-78.
- Mattick RP, 2008, Cochrane Database Syst Rev, 2, CD002207
Cited by
Items 201–300 of 1,000
Ait‐Daoud, N., Blevins, D., Khanna, S., Sharma, S., & Holstege, C. P. (2017) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2017.01.005 · Cited by 49
Baldacchino, A., Arbuckle, K., Petrie, D., & McCowan, C. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0438-5 · Cited by 49
Lee, J. W., Hulman, S., Musci, M. N., & Stang, E. (2015) · Population Health Management · doi:10.1089/pop.2014.0134 · Cited by 48
Wachman, E. M., Hayes, M. J., Sherva, R., Brown, M. S., Shrestha, H., Logan, B. A., Heller, N. A., Nielsen, D. A., & Farrer, L. A. (2016) · American Journal on Addictions · doi:10.1111/ajad.12483 · Cited by 48
Vilkins, A. L., Bagley, S. M., Hahn, K. A., Rojas-Miguez, F., Wachman, E. M., Saia, K., & Alford, D. P. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000339 · Cited by 48
Methadone Versus Buprenorphine for Opioid Use Dependence and Risk of Neonatal Abstinence Syndrome
Lemon, L. S., Caritis, S. N., Venkataramanan, R., Platt, R. W., & Bodnar, L. M. (2017) · Epidemiology · doi:10.1097/ede.0000000000000780 · Cited by 49
Early life opioid exposure and potential long-term effects
Harder, H. J., & Murphy, A. Z. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100156 · Cited by 48
Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
Fraser, R., Mauger, S., & Gill, K. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s39692 · Cited by 48
Psychometric assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale
Jones, H. E., Seashore, C. J., Johnson, E., Horton, E., O’Grady, K. E., Andringa, K., Grossman, M. R., Whalen, B. L., & Holmes, A. V. (2016) · American Journal on Addictions · doi:10.1111/ajad.12388 · Cited by 47
Self-citationModels of care for neonatal abstinence syndrome: What works?
Whalen, B. L., Holmes, A. V., & Blythe, S. L. (2019) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2019.01.004 · Cited by 47
Pregnancy Alters CYP- and UGT-Mediated Metabolism of Buprenorphine
Zhang, H., Bastian, J. R., Zhao, W., Chen, H., Shaik, I. H., Chaphekar, N., Caritis, S. N., & Venkataramanan, R. (2020) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000724 · Cited by 47
Mactier, H., Shipton, D., Dryden, C., & Tappin, D. M. (2013) · Addiction · doi:10.1111/add.12400 · Cited by 46
Federal and State Policy Efforts to Address Maternal Opioid Misuse: Gaps and Challenges
Saunders, J. B., Jarlenski, M., Levy, R. J., & Kozhimannil, K. B. (2017) · Women s Health Issues · doi:10.1016/j.whi.2017.10.011 · Cited by 46
Site-Level Variation in the Characteristics and Care of Infants With Neonatal Opioid Withdrawal
Young, L., Hu, Z., Annett, R. D., Das, A., Fuller, J. F., Higgins, R. D., Lester, B. M., Merhar, S. L., Simon, A. E., Ounpraseuth, S., et al. (2021) · PEDIATRICS · doi:10.1542/peds.2020-008839 · Cited by 46
Barriers to accessing opioid agonist therapy in pregnancy
Bedrick, B. S., O’Donnell, C. M., Marx, C. M., Friedman, H., Carter, E. B., Stout, M. J., & Kelly, J. C. (2020) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2020.100225 · Cited by 45
Merrill, J. O., & Duncan, M. H. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.06.008 · Cited by 45
Opioid Prescribing in Rural Family Practices: A Qualitative Study
Click, I. A., Basden, J. A., Bohannon, J. M., Anderson, H., & Tudiver, F. G. (2017) · Substance Use & Misuse · doi:10.1080/10826084.2017.1342659 · Cited by 45
Safety of Psychotropic Medications During Pregnancy
Raffi, E. R., Nonacs, R. M., & Cohen, L. S. (2019) · Clinics in Perinatology · doi:10.1016/j.clp.2019.02.004 · Cited by 45
Integrated vs nonintegrated treatment for perinatal opioid use disorder: retrospective cohort study
Goodman, D., Saunders, E. C., Frew, J. R., Arsan, C., Xie, H., Bonasia, K., Flanagan, V. A., Lord, S., & Brunette, M. F. (2021) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2021.100489 · Cited by 46
Konijnenberg, C., & Melinder, A. M. D. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04006.x · Cited by 44
Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy
Noormohammadi, A., Forinash, A., Yancey, A., Crannage, E., Campbell, K., & Shyken, J. (2016) · Annals of Pharmacotherapy · doi:10.1177/1060028016648367 · Cited by 40
Devlin, L. A., Breeze, J. L., Terrin, N. C., Pomar, E. M. G., Bada, H. S., Finnegan, L. P., O’Grady, K. E., Jones, H. E., Lester, B. M., & Davis, J. M. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.2275 · Cited by 44
Self-citationMethadone interrupts neural growth and function in human cortical organoids
Yao, H., Wu, W., Cerf, I., Zhao, H. W., Wang, J., Negraes, P. D., Muotri, A. R., & Haddad, G. G. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.102065 · Cited by 44
Non-invasive carbon dioxide monitoring in neonates: methods, benefits, and pitfalls
Sankaran, D., Zeinali, L. I., Iqbal, S., Chandrasekharan, P. K., & Lakshminrusimha, S. (2021) · Journal of Perinatology · doi:10.1038/s41372-021-01134-2 · Cited by 44
Smirk, C., Bowman, E., Doyle, L. W., & Kamlin, C. O. F. (2014) · Acta Paediatrica · doi:10.1111/apa.12603 · Cited by 44
Maternal buprenorphine treatment and fetal neurobehavioral development
Jansson, L. M., Vélez, M. L., McConnell, K., Spencer, N., Tuten, M., Jones, H. E., King, V. L., Gandotra, N., Milio, L. A., Voegtline, K., et al. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.01.040 · Cited by 44
Self-citationKongstorp, M., Bogen, I. L., Stiris, T., & Andersen, J. M. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.259531 · Cited by 43
Winhusen, T. M., Lofwall, M. R., Jones, H. E., Wilder, C. M., Lindblad, R., Schiff, D. M., Wexelblatt, S. L., Merhar, S. L., Murphy, S. M., Greenfield, S. F., et al. (2020) · Contemporary Clinical Trials · doi:10.1016/j.cct.2020.106014 · Cited by 43
Self-citationChiang, Y., Hung, T., & Ho, I. (2013) · Addiction Biology · doi:10.1111/adb.12055 · Cited by 43
Maternal Buprenorphine Maintenance and Lactation
Jansson, L. M., Spencer, N., McConnell, K., Vélez, M. L., Tuten, M., Harrow, C., Jones, H. E., Swortwood, M. J., Barnes, A. J., Scheidweiler, K. B., et al. (2016) · Journal of Human Lactation · doi:10.1177/0890334416663198 · Cited by 43
Self-citationVelasco, B., Mohamed, E., & Sato‐Bigbee, C. (2021) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2021.107002 · Cited by 42
Predictors of treatment retention in postpartum women prescribed buprenorphine during pregnancy
O’Connor, A. B., Uhler, B., O’Brien, L. M., & Knuppel, K. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.12.001 · Cited by 42
Opioid analgesics and narcotic antagonists
Ghodse, A. H., & Galea, S. (2012) · Side effects of drugs annual · doi:10.1016/b978-0-444-59499-0.00008-8 · Cited by 42
Treatment of Opioid Dependence in the Setting of Pregnancy
Young, J. L., & Martin, P. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2012.03.008 · Cited by 41
Self-citationOpioid treatment for opioid withdrawal in newborn infants
Zankl, A., Martin, J., Davey, J. G., & Osborn, D. A. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002059.pub4 · Cited by 41
The immediate and long-term effects of prenatal opioid exposure
Yen, E., & Davis, J. M. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.1039055 · Cited by 41
Are Male Neonates More Vulnerable to Neonatal Abstinence Syndrome Than Female Neonates?
Unger, A., Jagsch, R., Bäwert, A., Winklbaur, B., Rohrmeister, K., Martin, P., Coyle, M. G., & Fischer, G. (2011) · Gender Medicine · doi:10.1016/j.genm.2011.10.001 · Cited by 41
Self-citationFactors Associated with Buprenorphine versus Methadone use in Pregnancy
Krans, E. E., Bogen, D. L., Richardson, G. A., Park, S. Y., Dunn, S. L., & Day, N. L. (2016) · Substance Abuse · doi:10.1080/08897077.2016.1146649 · Cited by 41
Maternal buprenorphine treatment and infant outcome
Jansson, L. M., Vélez, M. L., McConnell, K., Spencer, N., Tuten, M., Jones, H. E., Rios, R., King, V. L., Gandotra, N., Milio, L. A., et al. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.08.001 · Cited by 40
Self-citationPrenatal buprenorphine exposure and neonatal neurobehavioral functioning
Vélez, M. L., McConnell, K., Spencer, N., Montoya, L., Tuten, M., & Jansson, L. M. (2017) · Early Human Development · doi:10.1016/j.earlhumdev.2017.11.009 · Cited by 40
Non-pharmacological care for opioid withdrawal in newborns
Pahl, A., Young, L., Buus-Frank, M. E., Marcellus, L., & Soll, R. F. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013217.pub2 · Cited by 40
Neonatal Abstinence Syndrome: Presentation and Treatment Considerations
Kaltenbach, K. A., & Jones, H. E. (2016) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000207 · Cited by 41
Self-citationNechanská, B., Mravčík, V., Skurtveit, S. O., Lund, I. O., Gabrhelík, R., Engeland, A., & Handal, M. (2018) · Addiction · doi:10.1111/add.14192 · Cited by 39
Gestational changes in buprenorphine exposure: A physiologically‐based pharmacokinetic analysis
Zhang, H., Kalluri, H. V., Bastian, J. R., Chen, H., Alshabi, A. M., Caritis, S. N., & Venkataramanan, R. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13642 · Cited by 40
Maternal stress and behavioral adaptation in methadone- or buprenorphine-exposed toddlers
Sarfi, M., Sundet, J. M., & Waal, H. (2013) · Infant Behavior and Development · doi:10.1016/j.infbeh.2013.08.006 · Cited by 39
P-gp/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphine
Liao, M. Z., Gao, C., Shireman, L. M., Phillips, B., Risler, L. J., Neradugomma, N. K., Choudhari, P., Prasad, B., Shen, D. D., & Mao, Q. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.01.018 · Cited by 39
Holbrook, A. M., Baxter, J. K., Jones, H. E., Heil, S. H., Coyle, M. G., Martin, P., Stine, S. M., & Kaltenbach, K. A. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04042.x · Cited by 39
Self-citationMethadone versus buprenorphine for the treatment of opioid abuse in pregnancy: science and stigma
Holbrook, A. M. (2015) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2015.1059625 · Cited by 38
Prenatal opioid exposure – Increasing evidence of harm
Mactier, H., & Hamilton, R. (2020) · Early Human Development · doi:10.1016/j.earlhumdev.2020.105188 · Cited by 38
Ordean, A., Kahan, M., Graves, L. E., Abrahams, R., & Kim, T. H. M. (2015) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30311-x · Cited by 38
Serra, A. E., Lemon, L. S., Mokhtari, N., Parks, W. T., Catov, J. M., Venkataramanan, R., & Caritis, S. N. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.12.016 · Cited by 38
Effects of opioids on the parental brain in health and disease
Swain, J. E., Ho, S.-H. S., Fox, H. C., Garry, D. J., & Brummelte, S. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100766 · Cited by 38
Pharmacological treatment of opioid use disorder in pregnancy
Rodriguez, C. E., & Klie, K. A. (2019) · Seminars in Perinatology · doi:10.1053/j.semperi.2019.01.003 · Cited by 37
Unger, A., Jagsch, R., Jones, H. E., Arria, A. M., Leitich, H., Rohrmeister, K., Aschauer, C., Winklbaur, B., Bäwert, A., & Fischer, G. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03440.x · Cited by 37
Self-citationShould pregnant women with substance use disorders be managed differently?
Metz, V. E., Köchl, B., & Fischer, G. (2012) · Neuropsychiatry · doi:10.2217/npy.11.74 · Cited by 37
Self-citationAlcohol, Tobacco and Drug Use as Reasons for Abortion
Roberts, S. C. M., Avalos, L. A., Sinkford, D., & Foster, D. G. (2012) · Alcohol and Alcoholism · doi:10.1093/alcalc/ags095 · Cited by 37
Neonatal Abstinence Syndrome: Therapeutic Interventions
Sublett, J. (2012) · MCN The American Journal of Maternal/Child Nursing · doi:10.1097/nmc.0b013e31826e978e · Cited by 37
McCarthy, J. J. (2011) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2011.600371 · Cited by 37
Buprenorphine Dosing for the Treatment of Opioid Use Disorder Through Pregnancy and Postpartum
Martin, C. E., Shadowen, C. R., Thakkar, B., Oakes, T., Gal, T. S., & Moeller, F. G. (2020) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-020-00221-z · Cited by 36
Chronic Opioid Use During Pregnancy
Stanhope, T. J., Gill, L. A., & Rose, C. H. (2013) · Clinics in Perinatology · doi:10.1016/j.clp.2013.05.015 · Cited by 36
Opioid Dependent and Pregnant: What Are the Best Options for Mothers and Neonates?
Unger, A., Metz, V. E., & Fischer, G. (2012) · Obstetrics and Gynecology International · doi:10.1155/2012/195954 · Cited by 36
Self-citationMaternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study
McQueen, K., Murphy-Oikonen, J., & Desaulniers, L. (2015) · Maternal and Child Health Journal · doi:10.1007/s10995-015-1689-y · Cited by 36
Wurst, K., Zedler, B. K., Joyce, A. R., Sasinowski, M., & Murrelle, E. L. (2016) · Substance Abuse Research and Treatment · doi:10.4137/sart.s38887 · Cited by 35
Healthcare Patterns of Pregnant Women and Children Affected by OUD in 9 State Medicaid Populations
Jarlenski, M., Kim, J. Y., Ahrens, K. A., Allen, L., Austin, A. E., Barnes, A. J., Crane, D. A., Lanier, P., Mauk, R., Mohamoud, S., et al. (2021) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000780 · Cited by 35
Visual Selective Attention Is Impaired in Children Prenatally Exposed to Opioid Agonist Medication
Konijnenberg, C., & Melinder, A. M. D. (2014) · European Addiction Research · doi:10.1159/000366018 · Cited by 35
Buprenorphine Implant for Opioid Addiction
Ling, W. W. (2012) · Pain Management · doi:10.2217/pmt.12.26 · Cited by 35
Changes in methadone maintenance therapy during and after pregnancy
Albright, B. B., de la Torre, L., SKIPPER, B. J., Price, S., Abbott, P., & Rayburn, W. F. (2011) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2011.05.002 · Cited by 35
Guttmann, A., Blackburn, R. M., Amartey, A., Zhou, L., Wijlaars, L. P. M. M., Saunders, N. R., Harron, K. L., Chiu, M., & Gilbert, R. E. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002974 · Cited by 35
Bishop, D., Borkowski, L., Couillard, M., Allina, A., Baruch, S., & Wood, S. F. (2017) · Cited by 34
Jilani, S. M., Jordan, C. J., Jansson, L. M., & Davis, J. M. (2021) · Journal of Perinatology · doi:10.1038/s41372-020-00893-8 · Cited by 34
Abu, Y. F., Singh, S., Tao, J., Chupikova, I., Singh, P. K., Meng, J., & Roy, S. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2292224 · Cited by 34
Odds ratio vs risk ratio in randomized controlled trials
Balasubramanian, H., Ananthan, A., Rao, S. C., & Patole, S. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2015.1022494 · Cited by 34
Bachhuber, M. A., Mehta, P., Faherty, L. J., & Saloner, B. K. (2017) · Medical Care · doi:10.1097/mlr.0000000000000803 · Cited by 34
Buprenorphine in Neonatal Abstinence Syndrome
Kraft, W. K. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.930 · Cited by 34
Jones, H. E., Kaltenbach, K. A., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O’Grady, K. E., Selby, P. L., Martin, P., Jansson, L. M., et al. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2011.653423 · Cited by 34
Self-citationHoyt, M. R., Shah, U. R., Cooley, J., & Temple, M. (2018) · International Journal of Obstetric Anesthesia · doi:10.1016/j.ijoa.2018.01.001 · Cited by 33
Systematic Review of Newborn Feeding Method and Outcomes Related to Neonatal Abstinence Syndrome
McQueen, K., Taylor, C., & Murphy-Oikonen, J. (2019) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1016/j.jogn.2019.03.004 · Cited by 33
Convertino, I., Sansone, A. C., Marino, A., Galiulo, M. T., Mantarro, S., Antonioli, L., Fornai, M., Blandizzi, C., & Tuccori, M. (2016) · Drug Safety · doi:10.1007/s40264-016-0435-8 · Cited by 32
Rice, W. R., Folger, A. T., Wexelblatt, S. L., & Hall, E. S. (2017) · American Journal of Perinatology · doi:10.1055/s-0037-1608634 · Cited by 32
Sutter, M. B., Watson, H., Bauers, A., JOHNSON, K., Hatley, M., Yonke, N., & Leeman, L. M. (2019) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.12960 · Cited by 32
Safety and Efficacy of Buprenorphine-Naloxone in Pregnancy: A Systematic Review of the Literature
Ordean, A., & Tubman-Broeren, M. (2023) · Pathophysiology · doi:10.3390/pathophysiology30010004 · Cited by 32
Rural, Pregnant, and Opioid Dependent: A Systematic Review
Jumah, N. A. (2016) · Substance Abuse Research and Treatment · doi:10.4137/sart.s34547 · Cited by 32
Initiation and Engagement with Methadone Treatment among Pregnant and Postpartum Women
Mattocks, K. M., Clark, R. E., & Weinreb, L. (2017) · Women s Health Issues · doi:10.1016/j.whi.2017.05.002 · Cited by 32
Impact of sex, race, and social determinants of health on neonatal outcomes
Alur, P., Holla, I., & Hussain, N. (2024) · Frontiers in Pediatrics · doi:10.3389/fped.2024.1377195 · Cited by 31
Nonopioid Management of Neonatal Abstinence Syndrome
Boucher, A. (2016) · Advances in Neonatal Care · doi:10.1097/anc.0000000000000371 · Cited by 31
Screening and Management of Substance Use in Pregnancy: A Review
Cook, J. L., Green, C. R., de la Ronde, S., Dell, C. A., Graves, L. E., Morgan, L., Ordean, A., Ruiter, P. J. A., Steeves, M., & Wong, S. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.07.017 · Cited by 32
Schlagal, C. R., Dunn, T. J., Xu, P., Felsing, D. E., Merritt, C. R., Manja, S., Fox, R. G., Buffington, S. A., Saade, G. R., Dineley, K. T., et al. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.03.014 · Cited by 31
Opioid Use in Pregnancy: A Review
Ryan, K. S., Prewitt, K. C., Hayer, S., Hedges, M. A., Benson, A. E., & Lo, J. O.-T. (2023) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000001094 · Cited by 31
Pharmacological Management of Opioid Use Disorder in Pregnant Women
Wilder, C. M., & Winhusen, T. M. (2015) · CNS Drugs · doi:10.1007/s40263-015-0273-8 · Cited by 31
Prescription drug use among pregnant women in opioid Maintenance Treatment
Lund, I. O., Skurtveit, S. O., Engeland, A., Furu, K., Ravndal, E., & Handal, M. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04049.x · Cited by 31
Management of women treated with buprenorphine during pregnancy
Alto, W. A., & O’Connor, A. B. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.04.001 · Cited by 31
The relationship between gestational age and the severity of neonatal abstinence syndrome
Gibson, K. S., Stark, S., Kumar, D., & Bailit, J. L. (2016) · Addiction · doi:10.1111/add.13703 · Cited by 31
Isemann, B. T., Stoeckle, E. C., Taleghani, A. A., & Mueller, E. W. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1948 · Cited by 31
Tolia, V. N., Murthy, K., Bennett, M., Miller, E. S., Benjamin, D. K., Smith, P. B., & Clark, R. H. (2017) · Journal of Perinatology · doi:10.1038/jp.2017.157 · Cited by 31
Lemon, L. S., Naimi, A. I., Caritis, S. N., Platt, R. W., Venkataramanan, R., & Bodnar, L. M. (2018) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12443 · Cited by 31
Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome
Jones, H. E., & Kraft, W. K. (2019) · Clinics in Perinatology · doi:10.1016/j.clp.2019.02.013 · Cited by 32
Self-citationManagement of Neonatal Abstinence Syndrome from Opioids
Grim, K. J., Harrison, T. E., & Wilder, R. T. (2013) · Clinics in Perinatology · doi:10.1016/j.clp.2013.05.004 · Cited by 31
First Trimester Use of Buprenorphine or Methadone and the Risk of Congenital Malformations
Suarez, E. A., Bateman, B. T., Straub, L., Hernández–Díaz, S., Jones, H. E., Gray, K. J., Connery, H. S., Davis, J. M., Lester, B. M., Terplan, M., et al. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.6986 · Cited by 30
Self-citation“Subutex is safe”: Perceptions of risk in using illicit drugs during pregnancy
Leppo, A. (2012) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2012.01.004 · Cited by 30
Shainker, S. A., Saia, K., & Lee-Parritz, A. (2012) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e3182788e8c · Cited by 30
Metadata
- Authors
- Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G.
- Affiliations
- Johns Hopkins University (US)
- Thomas Jefferson University (US)
- University of Vermont (US)
- Wayne State University (US)
- Brown University (US)
- University of Maryland, College Park (US)
- University of Toronto (CA)
- Vanderbilt University (US)
- Medical University of Vienna (AT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-12-09
- Volume
- 363
- Issue
- 24
- Pages
- 2320-2331
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC3073631
- OpenAlex
- W2025988777
- Cited by
- 986
- References
- 41
- Citations by year
- 2026: 33 · 2025: 38 · 2024: 44 · 2023: 56 · 2022: 45 · 2021: 59 · 2020: 67 · 2019: 97 · 2018: 51 · 2017: 139 · 2016: 72 · 2015: 58 · 2014: 63 · 2013: 56 · 2012: 78
- FWCI
- 46.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01 DA15832, R01DA015778, R01DA 017513, R01DA015764, R01DA015832, R01DA015741, R01DA015738, R01DA018410, R01DA018417)
- National Center for Research Resources (M01-RR-109, M01RR000095, M01-RR-00095)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- neonatal abstinence syndrome, methadone, buprenorphine, opioid dependence in pregnancy, prenatal opioid exposure, mu-opioid receptor agonists, neonatal hospital stay, neonatal head circumference
- MeSH terms
- Adult, Buprenorphine, Double-Blind Method, Female, Head, Humans, Infant, Newborn, Length of Stay, Methadone, Morphine, Opioid-Related Disorders, Narcotics, Neonatal Abstinence Syndrome, Pregnancy, Pregnancy Complications, Logistic Models, History, Ancient
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.